Xeris Biopharma Holdings, Inc.
SEC Filing List
XERS CIK: 0001867096
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Quarterly report pursuant to Section 13 ... | Xeris Biopharma Holdings, Inc. | 05/07/2026 | ||
| 8-K | Current report filing | Xeris Biopharma Holdings, Inc. | 05/07/2026 | ||
| 4 | Statement of changes in beneficial owner... | Hecht Beth | Xeris Biopharma Holdings, Inc. | 05/01/2026 | |
| DEF 14A | Definitive proxy statements | Xeris Biopharma Holdings, Inc. | 04/23/2026 | ||
| ARS | Annual report to security holders | Xeris Biopharma Holdings, Inc. | 04/23/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Xeris Biopharma Holdings, Inc. | 04/23/2026 | ||
| 8-K | Current report filing | Xeris Biopharma Holdings, Inc. | 04/21/2026 | ||
| 4 | Statement of changes in beneficial owner... | Hecht Beth | Xeris Biopharma Holdings, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Brady James Aloysius | Xeris Biopharma Holdings, Inc. | 04/01/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 03/30/2026 | ||
| No record found. | |||||
| Load More | |||||
